文献速递儿童心血管与肾脏

中国先天性心脏病治疗现状与未来展望

Current treatment outcomes of congenital heart disease and future perspectives.
PubMed 文献 · Lancet Child Adolesc Health · 2023-06-07

本文系统总结中国先天性心脏病的治疗结局与模式,指出中国拥有全球最大的先心病患者群体,总体治疗效果令人满意;但二尖瓣病变与儿童终末期心衰管理、儿科心脏团队建设、医疗资源可及性与公平性、全国数据库建设仍需加强。

要点

  • 中国先心病治疗总体结局满意,但二尖瓣病变和儿童终末期心衰管理仍需提升。
  • 需建立紧密的儿科心脏团队并加强医院间协作。
  • 先心病相关医疗资源需更可及、更公平,全国数据库需加强。

核心结论

  • 中国先心病治疗总体结局令人满意,但二尖瓣病变管理、儿童终末期心衰管理、儿科心脏团队建设、医院协作、医疗资源可及性与公平性及全国数据库仍需改进。

研究设计与样本

  • 本文为系列文章第二篇,系统总结中国当前先心病治疗结局,讨论潜在解决方案并提供未来展望。

主要发现

  • 中国拥有全球最多的先心病患者,疾病负担沉重,理解中国治疗结局与模式有助于全球先心病治疗进展。

临床怎么用

  • 应关注二尖瓣病变和儿童终末期心衰的管理改进,建立紧密的儿科心脏团队并加强医院间协作。
  • 应推动先心病医疗资源更可及、更公平,并加强全国性先心病数据库建设。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

China has the largest number of individuals with congenital heart disease (CHD) in the world and a heavy burden of CHD. Therefore, understanding current CHD treatment outcomes and patterns in China will contribute to global progress in CHD treatment and be a valuable experience. Generally, CHD treatment in China has satisfactory outcomes owing to the joint efforts by all relevant stakeholders across the country. However, efforts are needed to overcome the remaining challenges: management of mitral valve disease and paediatric end-stage heart failure needs to be improved; cohesive paediatric cardiology teams should be established and collaboration between hospitals enhanced; CHD-related medical resources need to be more accessible and equitable; and nationwide CHD databases should be enhanced. In the second paper of this Series, we aim to systematically summarise the current CHD treatment outcomes in China, discuss potential solutions, and provide future perspectives.

来源:Lancet Child Adolesc Health,查看原文。版权归原作者所有。

引用

  1. Ma K, He Q, Dou Z, et al. Current treatment outcomes of congenital heart disease and future perspectives. Lancet Child Adolesc Health. 2023. PMID: 37301213. doi:10.1016/S2352-4642(23)00076-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。